Overexpression of ubiquitous mitochondrial creatine kinase (uMtCK) accelerates tumor growth by inhibiting apoptosis of breast cancer cells and is associated with a poor prognosis in breast cancer patients

Biochemical and Biophysical Research Communications

Volumn 427, Issue 1, 2012, Pages 60-66

  Qian, Xiao Long ^a,b   Li, Ya Qing ^a,b   Gu, Feng ^a,b   Liu, Fang Fang ^a,b   Li, Wei Dong ^a,b   Zhang, Xin Min ^c   Fu, Li ^a,b,d  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

^d 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics   (China)

Author keywords

Apoptosis; Breast cancer; Cell crowding; Ubiquitous mitochondrial creatine kinase

Indexed keywords

BETA ACTIN; CASPASE 9; CYTOCHROME C; MITOCHONDRIAL CREATINE KINASE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENICITY; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; UPREGULATION; WEIGHT REDUCTION;

ADULT; AGED; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CREATINE KINASE, MITOCHONDRIAL FORM; FEMALE; HUMANS; MICE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; MUS MUSCULUS;

EID: 84867635450     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.147     Document Type: Article

References (25)

1. Kornacker M., Schlattner U., Wallimann T., Verneris M.R., Negrin R.S., Kornacker B., Staratschek-Jox A., Diehl V., Wolf J. Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis. Int. J. Cancer 2001, 94:513-519.
2. Wallimann T., Hemmer W. Creatine kinase in non-muscle tissues and cells. Mol. Cell. Biochem. 1994, 133:193-220.
3. Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 2000, 80:1107-1213.
4. Schlattner U., Tokarska-Schlattner M., Wallimann T. Mitochondrial creatine kinase in human health and disease. Biochim. Biophys. Acta 2006, 1762:164-180.
5. Onda T., Uzawa K., Endo Y., Bukawa H., Yokoe H., Shibahara T., Tanzawa H. Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma. Br. J. Cancer 2006, 94:698-709.
6. DeLuca M., Hall N., Rice R., Kaplan N.O. Creatine kinase isozymes in human tumors. Biochem. Biophys. Res. Commun. 1981, 99:189-195.
7. Kanemitsu F., Kawanishi I., Mizushima J., Okigaki T. Mitochondrial creatine kinase as a tumor-associated marker. Clin. Chim. Acta 1984, 138:175-183.
8. Martin K.J., Chen S.F., Clark G.M., Degen D., Wajima M., Von Hoff D.D., Kaddurah-Daouk R. Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells. J. Natl. Cancer 1994, I(86):608-613.
9. Pratt R., Vallis L.M., Lim C.W., Chisnall W.N. Mitochondrial creatine kinase in cancer patients. Pathology 1987, 19:162-165.
10. Becker S., Schneider F. Investigations on the function of creatine kinase in Ehrlich ascites tumor cells. Biol. Chem. Hoppe-Seyler 1989, 370:357-364.
11. Shimizu R. Clinical evaluation of mitochondrial creatine kinase levels in human tumors. Nippon Geka Hokan 1986, 55:96-105.
12. Tsung S.H. Creatine kinase activity and isoenzyme pattern in various normal tissues and neoplasms. Clin. Chem. 1983, 29:2040-2043.
13. Pang B., Zhang H., Wang J., Chen W.Z., Li S.H., Shi Q.G., Liang R.X., Xie B.X., Wu R.Q., Qian X.L., Yu L., Li Q.M., Huang C.F., Zhou J.G. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression. Prostate 2009, 69:1176-1187.
14. Cimino D., Fuso L., Sfiligoi C., Biglia N., Ponzone R., Maggiorotto F., Russo G., Cicatiello L., Weisz A., Taverna D. Identification of new genes associated with BCa progression by gene expression analysis of predefined sets of neoplastic tissues. Int. J. Cancer 2008, 123:1327-1338.
15. Murray J.I., Whitfield M.L., Trinklein N.D., Myers R.M., Brown P.O., Botstein D. Diverse and specific gene expression responses to stresses in cultured human cells. Mol. Biol. Cell 2004, 15:2361-2374.
16. Chen N.Y., Lai H.H., Hsu T.H., Lin F.Y., Chen J.Z., Lo H.C. Induction of apoptosis in human lung carcinoma A549 epithelial cells with an ethanol extract of Tremella mesenterica. Biosci. Biotechnol. Biochem. 2008, 72:1283-1289.
17. Zhang N., Kong X., Yan S., Yuan C., Yang Q. Huaier aqueous extract inhibits proliferation of BCa cells by inducing apoptosis. Cancer Sci. 2010, 101:2375-2383.
18. Zhang Q., Zhang Y., Wang S.Z., Wang N., Jiang W.G., Ji Y.H., Zhang S.L. Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer. J. Exp. Clin. Cancer Res. 2012, 31:1-9.
19. Ly J.D., Grubb D.R., Lawen A. The mitochondrial membrane potential (ΔΨm) in apoptosis; an update. Apoptosis 2003, 8:115-128.
20. Niu J., Gu X., Ahmed N., Andrews S., Turton J., Bates R., Agrez M. The aVβ6 integrin regulates its own expression with cell crowding: implications for tumour progression. Int. J. Cancer 2001, 92:40-48.
21. Li H., Zhu H., Xu C., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94:491-501.
22. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94:481-490.
23. Desagher S., Martinou J.C. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 2000, 10:369-377.
24. Jiang J., Belikova N.A., Hoye A.T., Zhao Q., Epperly M.W., Greenberger J.S., Wipf P., Kagan V.E. A mitochondria-targeted nitroxide/hemigramicidin S conjugate protects mouse embryonic cells against gamma irradiation. Int. J. Radiat. Oncolo. 2008, 70:816-825.
25. Lenz H., Schmidt M., Welge V., Kueper T., Schlattner U., Wallimann T., Elsasser H.P., Wittern K.P., Wenck H., Staeb F. Inhibition of cytosolic and mitochondrial creatine kinase by siRNA in HaCaT-and HeLaS3-cells affects cell viability and mitochondrial morphology. Mol. Cell. Biochem. 2007, 306:153-162.